Hepatitis C Virus
Hepatitis C virus recurrence and graft fibrosis is treatable following liver transplantation
Published in Blood Weekly, April 27th, 2006
"Chronic HCV is a principal indication for liver transplantation. Recurrent viral infection is inevitable and graft disease is common. We report tolerability, safety and efficacy of pegylated interferon alpha 2b (PEG-IFN) monotherapy for patients with HCV recurrence and fibrosis after liver transplantation," wrote M. Heydtmann and colleagues, Queen Elizabeth Hospital.
"Repeated measurements of serum HCV titer permitted assessment of the kinetics of the antiviral response for all patients. We...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-04-27)
More Articles from Blood Weekly
- Cardiology
In high-transfusion-risk cardiac surgery, aprotinin and tranexamic acid are similarly effective - Tissue Engineering
Cell-cell competition replaces functional organ tissue under nonselective conditions - Tissue Engineering
Neural progenitor and endothelial cells cocultured on hydrogel forms functional vascular networks - Twin-to-Twin Transfusion Syndrome
U.S. FDA approves humanitarian device exemption for treatment of Twin-to-Twin Transfusion syndrome - Arterial Thrombosis
Targeting PAR1-PAR4 may offer opportunity to prevent arterial thrombosis - Bone Marrow
Bone marrow stromal cell proliferation and osteogenic potential is enhanced by osterix - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
